|
"gu s"的相關文件
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
|
Qin S.; Ren Z.; Feng Y.-H.; Yau T.; Wang B.; Zhao H.; Bai Y.; Gu S.; Li L.; Hernandez S.; Xu D.-Z.; Mulla S.; Wang Y.; Shao H.; ANN-LII CHENG |
| 國立成功大學 |
2022 |
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study: RAM/PL + BSC for advanced HCC
|
Shao, G.;Bai, Y.;Yuan, X.;Chen, X.;Gu, S.;Gu, K.;Hu, C.;Liang, H.;Guo, Y.;Wang, J.;Yen, C.-J.;Lee, V.H.-F.;Wang, C.;Widau, R.C.;Zhang, W.;Liu, J.;Zhang, Q.;Qin, S. |
| 臺大學術典藏 |
2020-01-13T08:22:33Z |
Ferroelectric HfZrOₓ FETs on SOI Substrate with Reverse-DIBL (Drain-Induced Barrier Lowering) and NDR (Negative Differential Resistance)
|
Chen, K.; Gu, S.; Wang, Z.; Liao, C.; Chou, Y.; Hong, R.; Chen, S.; Chen, H.; Siang, G.; Le, J.; Chen, P.; Liao, M.; Li, K.; Chang, S.T.; Lee, M.H.; MING-HAN LIAO |
| 國立成功大學 |
2020 |
Analysis and Prediction of Overloaded Extra-Heavy Vehicles for Highway Safety Using Machine Learning
|
Lin, Y.-H.;Gu, S.;Wu, Wu W.-S.;Wang, R.;Wu, F. |
| 國立成功大學 |
2019 |
AIM 2019 challenge on real-world image super-resolution: Methods and results
|
Lugmayr, A.;Danelljan, M.;Timofte, R.;Fritsche, M.;Gu, S.;Purohit, K.;Kandula, P.;Suin, M.;Rajagopalan, A.N.;Joon, N.H.;Won, Y.S.;Kim, G.;Kwon, D.;Hsu, C.-C.;Lin, C.-H.;Huang, Y.;Sun, X.;Lu, W.;Li, J.;Gao, X.;Bell-Kligler, S. |
顯示項目 1-5 / 5 (共1頁)
1
每頁顯示[10|25|50]項目
|
